What changedvs. the 10-Q for 2026 Q2 — 5 notable changesView full comparison
    • Added: “Gross margin for the three and nine months ended July 31, 2026 increased due to higher sales volume, a net benefit from tariff refunds, lower corporate costs and savings from restructuring programs partially offset by higher variable pay and warranty expenses when compared to…”
    • Rewritten: “The provision of site service costs to, and lease income from Keysight Technologies, Inc. contributed income of $4 million. The costs associated with these services are reported within income from operations. For the nine months ended July 31, 2026, other income (expense), net…”
    • Added: “Revenue growth was strong in the diagnostics and clinical market led by revenue from our genomics and companion diagnostics businesses with modest growth in our pathology business. The decline in revenue in the academia and government market was driven by revenue declines in our…”
    • Rewritten: “11 percent in the Americas with no currency impact, increased 3 percent in Europe with no currency impact and increased 6 percent in Asia Pacific with no currency impact when compared to the same period last year. Revenue growth in the Americas was driven by strength in our…”
    • Rewritten: “ACQUISITION Acquisition of Biocare On June 24, 2026, we acquired 100 percent of the outstanding capital stock of BC Midco I, Inc. ("Biocare") for a net consideration paid of $950 million. Biocare is a leading provider of clinical and research solutions and is included within our…”

    Company

    Agilent Technologies, Inc.

    Form

    10-Q

    Timestamp

    4:11 PM Sep 1, 2026

    Views

    19

    Create a free CapEdge Account

    • Track your favorite companies

    • Receive email alerts for new filings

    • Personalized dashboard of news

    • Access all data and search results

    Log InSign Up

    Actions

    Font Size

    Search this filing

    Table of Contents

    Log in or sign up to navigate this filing by section.

    Similar Filings

    Exhibits

    Related Transcript